Amy L. Dunn

2.6k total citations
79 papers, 1.4k citations indexed

About

Amy L. Dunn is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Amy L. Dunn has authored 79 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 19 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Amy L. Dunn's work include Hemophilia Treatment and Research (52 papers), Platelet Disorders and Treatments (26 papers) and Blood Coagulation and Thrombosis Mechanisms (26 papers). Amy L. Dunn is often cited by papers focused on Hemophilia Treatment and Research (52 papers), Platelet Disorders and Treatments (26 papers) and Blood Coagulation and Thrombosis Mechanisms (26 papers). Amy L. Dunn collaborates with scholars based in United States, Canada and Brazil. Amy L. Dunn's co-authors include Thomas C. Abshire, Michael T. Busch, Bryce A. Kerlin, Victor S. Blanchette, Joseph Stanek, Karin Gaensler, Xiao Luo, Xu Tan, Kevin M. Sullivan and Binbin Deng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and Blood.

In The Last Decade

Amy L. Dunn

73 papers receiving 1.4k citations

Peers

Amy L. Dunn
Connie H. Miller United States
Francesca Masiello Italy
Pradeep Mathew Poonnoose India
Gary Benson United Kingdom
Can Balkan Türkiye
Rebecca Davies United Kingdom
Giuseppe Lassandro Italy
D. Bachir France
Junna Ye China
Birgitte Klug Albertsen Denmark
Connie H. Miller United States
Amy L. Dunn
Citations per year, relative to Amy L. Dunn Amy L. Dunn (= 1×) peers Connie H. Miller

Countries citing papers authored by Amy L. Dunn

Since Specialization
Citations

This map shows the geographic impact of Amy L. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy L. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy L. Dunn more than expected).

Fields of papers citing papers by Amy L. Dunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy L. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy L. Dunn. The network helps show where Amy L. Dunn may publish in the future.

Co-authorship network of co-authors of Amy L. Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Amy L. Dunn. A scholar is included among the top collaborators of Amy L. Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy L. Dunn. Amy L. Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Malec, Lynn, Amy L. Dunn, Manuel Carção, et al.. (2023). Treatment of Bleeding Episodes with Efanesoctocog Alfa in Children with Severe Hemophilia A in the XTEND-Kids Phase 3 Study. Blood. 142(Supplement 1). 3993–3993.
3.
Rodriguez, Vilmarie, et al.. (2023). A regional anticoagulation program improves safety and outcomes for both children and adults. Journal of Thrombosis and Thrombolysis. 56(1). 27–36.
4.
Mahlangu, Johnny, Susan Shapiro, Margareth C. Ozelo, et al.. (2023). Efficacy and safety of valoctocogene roxaparvovec gene transfer for severe hemophilia A: results from the GENEr8-1 three-year analysis. Hämostaseologie. 43(S 01). S96–S96. 1 indexed citations
5.
Malec, Lynn, Flora Peyvandi, Anthony K.C. Chan, et al.. (2023). LB 01.1 Efanesoctocog Alfa Prophylaxis for Previously Treated Patients <12 Years of Age with Severe Hemophilia A. Research and Practice in Thrombosis and Haemostasis. 7. 100288–100288. 3 indexed citations
6.
Stanek, Joseph, et al.. (2023). HTRS2023.P2.5 Joint surveillance with ultrasound in pediatric hemophilia A patients on emicizumab: a single institution retrospective review. Research and Practice in Thrombosis and Haemostasis. 7. 100229–100229.
7.
Mahlangu, Johnny, Annette von Drygalski, Susan Shapiro, et al.. (2023). OC 20.1 Bleeding, FVIII Activity, and Safety 3 Years After Gene Transfer with Valoctocogene roxaparvovec: Results from GENEr8-1. Research and Practice in Thrombosis and Haemostasis. 7. 100459–100459. 2 indexed citations
8.
Pierce, Glenn F., Saliou Diop, Amy L. Dunn, et al.. (2022). Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded Humanitarian Aid Program of the World Federation of Hemophilia after 5 years. The Lancet Haematology. 9(9). e689–e697. 38 indexed citations
9.
Rodriguez, Vilmarie, Joseph Stanek, Bryce A. Kerlin, & Amy L. Dunn. (2022). Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists. Clinical and Applied Thrombosis/Hemostasis. 28. 2985260346–2985260346. 6 indexed citations
10.
Mazzaccaro, Richard J., et al.. (2021). Don’t Forget the Flu – Determining the Etiology of Infective Myositis in a Child: A Case Report. SHILAP Revista de lepidopterología. 5(1). 105–108. 2 indexed citations
11.
Tolend, Mirkamal, Haris Majeed, Marcelo Bordalo Rodrigues, et al.. (2020). Critical appraisal of the International Prophylaxis Study Group magnetic resonance image scale for evaluating haemophilic arthropathy. Haemophilia. 26(4). 565–574. 10 indexed citations
12.
Stanek, Joseph, et al.. (2019). Anti-Factor Xa–Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. The Journal of Pediatrics. 209. 212–219.e1. 8 indexed citations
13.
14.
Croteau, Stacy E., Michael J. Callaghan, Joanna A. Davis, et al.. (2018). Focusing in on use of pharmacokinetic profiles in routine hemophilia care. Research and Practice in Thrombosis and Haemostasis. 2(3). 607–614. 13 indexed citations
15.
16.
17.
Sharma, Ruchika, Amy L. Dunn, Shawn M. Jobe, Traci Leong, & Shannon L. Meeks. (2017). Thrombin Generation in Patients with Severe Hemophilia A May Be Variable but Predictive of Response to Treatment. Blood. 130. 3687–3687. 1 indexed citations
18.
Manco‐Johnson, Marilyn J., M L Manco-Johnson, Sharon Funk, et al.. (2013). Long-Term Orthopedic Effects Of Delaying Prophylaxis In Severe Hemophilia A Until Age 6 Years: Results Of The Joint Outcome Study Continuation (JOSc). Blood. 122(21). 210–210. 6 indexed citations
19.
Dunn, Amy L.. (2009). Malignancy in patients with haemophilia: a review of the literature. Haemophilia. 16(3). 427–436. 23 indexed citations
20.
Berg, H. Marijke van den, Amy L. Dunn, Kathelijn Fischer, & Victor S. Blanchette. (2006). Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy. Haemophilia. 12(s3). 159–168. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Connie H. Miller Breakdown of academic impact, for papers by Francesca Masiello Breakdown of academic impact, for papers by Pradeep Mathew Poonnoose Breakdown of academic impact, for papers by Gary Benson Breakdown of academic impact, for papers by Can Balkan Breakdown of academic impact, for papers by Rebecca Davies Breakdown of academic impact, for papers by Giuseppe Lassandro Breakdown of academic impact, for papers by D. Bachir Breakdown of academic impact, for papers by Junna Ye Breakdown of academic impact, for papers by Birgitte Klug Albertsen
Rankless by CCL
2026